Introduction
In recent years, epigenetics has emerged as one of the most rapidly expanding and dynamic research areas in biology that investigates the genome function in the regulation of an impressive diversity of cellular processes in homeostasis and disease (Sweatt, 2013) . Although the genomic sequence of many organisms has been completed, understanding how DNA sequences are deciphered in the context of individual cell types or specific environmental conditions represents the fundamental question of epigenetics. Tremendous advances in massively parallel sequencing techniques have revolutionized the field of epigenetics, and large-scale epigenomic projects, such as the Encyclopedia of DNA Elements (Stamatoyannopoulos, 2012) and the NIH Epigenomic Roadmap (Bernstein et al., 2010) , have been instrumental in identifying the functional elements of the genome and their contribution to human diseases by generating detailed maps of chromatin states of distinct cell types and tissues. Because epigenetic mechanisms play central roles in many neuronal processes, a deeper understanding of distinct epigenetic signatures of the neuronal genome also has the potential to tackle their deregulation into a broad spectrum of brain diseases (Telese et al., 2013) . These and other aspects of epigenetics research were addressed at the Keystone Symposia on Neuroepigenetics. The conference featured a diverse group of outstanding scientists, including plenary speakers and junior researchers, reporting their latest findings during an exciting 3-day agenda. The symposia was a tremendous success supported by NIH Director's Fund and organized by Hongjun Song (Johns Hopkins University, USA) and Li-Huei Tsai (Massachusetts Institute of Technology, USA); the program that these 2 leading researchers developed and their selection of presenters were key to meet the goal of pushing the boundaries in the emerging field of neuroepigenetics.
Keynote session
Two leading pioneers of the field delivered the first keynote session: Fred H. Gage (The Salk Institute for Biological Studies, USA) and Micheal E. Greenberg (Harvard Medical School, USA). Fred Gage described his journey in studying the role of transposable elements in human evolution by identifying the molecular differences between human and nonhuman primates based on cutting-edge techniques that incorporate high-throughput sequencing epigenomic approaches with the establishment of induced pluripotent stem cells (iPSCs) from human, chimpanzee, and bonobo. Comparative gene expression analysis of specie-specific iPSCs revealed differences in the regulation of long interspersed element 1 (LINE-1) transposons, which are the only known active transposons in the human genome (Marchetto et al., 2013) . Recent findings from Gage's laboratory and others indicated that those elements are expressed not only in the germ line but also in the brain, challenging the dogma that the genome of postmitotic neurons is static and suggesting that they drive genetic heterogeneity across neurons in the same Neuroepigenetics 2 (2015) 9-12 E-mail address: ftelese@ucsd.edu. individual and, therefore, they might have a role in dictating individual behavior and contributing to vulnerability to disease (Guffanti et al., 2014; Kazazian, 2004; Muotri et al., 2005) . In his inspiring talk, Fred Gage presented sequencing data to identify novel nonreference L1 insertions and provided evidence that LINE-1 repeats exhibit different mobility in nonprimate compared to humans, supporting the hypothesis that LINE-1 transposition could be considered as potential driver of genomic innovation underlying adaptive changes in evolution. Given that epigenetic mechanisms, such as DNA methylation, are crucial to control the mobilization of transposable elements in the genome, the study of epigenetic regulation of their mobility has major implications in all areas of neuroscience (Erwin et al., 2014) .
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The second lecture by Michael Greenberg focused on his careerlong research interest regarding the function of gene expression programs activated by neuronal activity at the level of synapses and transduced into the nucleus by signaling molecules that ultimately target transcription factors and chromatin regulators (West and Greenberg, 2011) . The most intriguing aspect of his presentation was his recent work on the misregulation of long gene expression in the brain when MECP2 is mutated in human or mouse models of Rett syndrome (Gabel et al., 2015) . Combining genomic profiling of MeCP2 and genome-wide base pair resolution DNA methylation assays, it emerged that MECP2 represses long genes by binding to a form of methylated DNA enriched in the brain. Because the long genes repressed by MeCP2 are enriched in functional annotation of neuronal functions, Michael Greenberg proposed the idea that disruption of long gene expression might be a general mechanism underlying the neurological dysfunctions in Rett syndrome. It was exciting to hear how the inhibition of topoisomerases with topotecan, a drug commonly used as a chemotherapeutic agent, leads to a dose-dependent reversal of long gene expression, which inspired novel ideas for developing methods to rebalance long gene expression as a strategy to correct neural dysfunction in neurodevelopmental disorders.
Epigenetic mechanisms in reprogramming
Induced pluripotent stem cell technology represents one of the major advances in modeling of neurological disorders in vitro (Nityanandam and Baldwin, 2015) . iPSC-derived neurons represent a powerful strategy for elucidating disease pathogenesis for drug discovery and development, for personalized medicine, and eventually for regenerative cell therapy, as suggested by many talks and posters presented at this meeting. However, the standard transdifferentiation protocol, which relies on the forced expression of neural lineage-specific transcription factors, is a long process with multiple steps that might increase the heterogeneity of the final neuronal population. In this context, XiangDong Fu (University of California, San Diego, CA, USA), a leader in the research area of RNA splicing, presented his recent work on an innovative and fast method for direct conversion of somatic cells to functional neurons based on repressing the expression of a single RNA binding protein, PTB (Xue et al., 2013) . Researchers led by Xiang-Dong Fu elucidated the molecular feedback loops that modulate the repression of PTB during neuronal differentiation when a microRNA-regulated splicing event causes the switch to the neuronal-specific isoform of PTB.
Many discussions at this meeting pivoted on the urgent need of efficient protocols for transdifferentiation to specific neuronal subtypes and supported the notion that the epigenomic profiling of these cells is a crucial strategy for mechanistic characterization of these cells and for developing novel protocols.
Epigenetic mechanisms in regulating synapse formation, plasticity, and behavior Long-standing themes such as regulation of synaptic plasticity were included in the program, and various talks proposed novel viewpoints in the molecular mechanisms underlying cognitive functions. A novel perspective was offered by Li-Huei Tsai, who has dedicated her career to elucidate molecular and cellular mechanisms of cognition with particular emphasis on models of Alzheimer disease. She presented her latest findings in the regulation of immediate early genes, which involves generation of DNA double strand breaks within their promoters to relieve a topological constraint that imposes another layer of regulation in the fast response of neurons to experiencedependent changes. This provocative finding inspired questions regarding mechanisms of DNA repair in postmitotic neurons and might have major implications in the study of neurodegenerative pathways.
David Sweatt (University of Alabama at Birmingham, USA) presented his recent work on novel mechanisms of epigenetic regulation of associative conditioning that involve recently identified extracoding RNAs, suggesting that neuronal activity-dependent transcription modulates DNA methylation (Di Ruscio et al., 2013) . Those noncoding RNA molecules are generated from coding genes and have the ability to block DNA methylation events by forming secondary structures that interact with the methyltransferase DNMT1. By using deep sequencing approaches to profile the transcriptome and methylome of neuronal cultures, it emerged that the presence of extracoding RNAs may predict gene-specific methylation status. This epigenetic mechanism is involved in the regulation of associative conditioning in the hippocampus, as demonstrated by altered learning behaviors of mice previously injected with antisense oligos interfering with specific extracoding RNAs.
In addition, this session highlighted novel groundbreaking discoveries in the epigenetic regulation of synaptic and behavioral plasticity mediated by methylation events that dynamically target both DNA and RNA. Particularly, Hongjun Song covered the mechanisms of neuronal activity-induced active DNA demethylation pathways that involve TET enzymatic machineries to convert 5-methylcytosine to 5-hydroxylmethylcytosine. Tet3 expression is dynamically regulated by synaptic activity and in turn effects excitatory glutamatergic transmission by modulating the amount of surface GluR1 at a transcriptional level (Yu et al., 2015) . Timothy Bredy (Queensland Brain Institute, Australia) talked about RNA modifications, such as N6-methyladenosine, as a crucial epigenetic mechanism in the fine tuning of gene expression related to adaptation.
The increasing amount of epigenetic modifications associated to experience-dependent changes in the brain and linking epigenetic alterations to development of neurological disorders provoked fertile discussions regarding epigenetic modifications as potential targets for drug treatment. Jeffrey S. Ney (Janssen R&D/Johnson and Johnson Innovation, Cambridge, MA, USA) portrayed the latest advances in the translational use of neuroepigenetic discoveries as epigenetic therapies for brain disorders. It emerged that combining genomic sequencing and expression data might represent a critical strategy to better define the druggable epigenomes. Although many of the epigenetic drugs hold great promises, such as HDAC inhibitors as treatment for cognitive impairments, many challenges are still unsolved, such as efficient delivery through the blood-brain barrier, safety, and tolerability for chronic treatments.
Molecular mechanisms
Experts in the field of epigenetics presented their overview of how diverse signaling transduction pathways affect behavioral processes by modulating epitranscriptomic events. Michael G. Rosenfeld (University of California, San Diego, CA, USA) presented his latest findings unraveling unexpected roles of enhancers as transcription units, global roles of noncoding RNAs, and dynamic changes in nuclear architecture in model systems relevant to cancer, development, aging, and brain plasticity Puc et al., 2015; Skowronska-Krawczyk et al., 2014) . His laboratory identified the epigenomic signature underlying learning and memory processes activated by the Reelin signaling pathway, which is associated with many neuropsychiatric disorders. The LRP8-Reelin-regulated enhancers orchestrate the transcriptional changes occurring during hippocampal associative learning and memory formation as a consequence of a novel synapse-to-nucleus signaling involving the γ-secretase-dependent release of the LRP8 intracellular domain that serves as a messenger molecule to transduce synaptically generated signals in the nucleus (Telese et al., 2015) .
Paolo Sassone-Corsi (University of California, Irvine, USA) illustrated a comprehensive picture of his long-lasting interest in deciphering the epigenetic language of the circadian clock (Asher and Sassone-Corsi, 2015) . He presented his latest findings regarding the oscillatory changes in gene expression as a strategy of epigenomic regulation of the circadian rhythm. In the most inspiring part of his talk, Paolo Sassone-Corsi described a novel link between energy metabolism, epigenetics, and the circadian clock, showing how the cellular metabolic processes in response to nutrients are intimately linked to chromatin remodeling processes through cross-talk mechanisms that involve NAD + -mediated metabolism, histone posttranslational modifications, and enzymatic feedback loops mediated by the histone deacetylases and histone methyltransferase (Aguilar-Arnal et al., 2015) .
The talk from Isabelle Mansuy (Brain Research Institute, ETH Zurich, Switzerland) focused on transgenerational epigenetics, a topic that has recently attracted both interest and debate in the field by proposing epigenetic changes as a candidate mechanism to explain how an organism can transmit learned behaviors or traits to its offspring (Heard and Martienssen, 2014) . By using an experimental model of early traumatic stress in mice, she provided evidence that traumatic events, such as unpredictable maternal separation and maternal exposure to stress, can strongly influence the behaviors of the offspring inducing depressive behaviors and cognitive dysfunction across several generations (Gapp et al., 2014b) . She presented her latest findings indicating that these phenomena are transmitted across generations thorough male sperms and are associated with 3 potential nongenetic mechanisms: DNA methylation of CpG islands of several genes, post-translational modifications of histone tails, and altered expression of noncoding RNAs (Gapp et al., 2014a) . The challenge remains to provide evidence for the causality link between epigenetic changes in sperm cells and behavioral effects across generations.
Epigenomes
The need of finding the right intersections between traditional approaches that have been instrumental in studying neuronal functions, such as cellular and behavioral studies of various genetic models, and fine mechanistic insights provided by the plethora of "omic" strategies was extensively covered by researchers at the forefront of this field, which illustrated the rapid advances and unique opportunities delivered by large-scale projects of relevance to the neuroscience community (Romanoski et al., 2015) .
Manolis Kellis (Broad Institute of MIT and Harvard) presented some of the landmark achievements of the NIH Roadmap Epigenomics Mapping Consortium, a public resource of reference epigenomes that provide information on how key genomic regulatory elements orchestrate gene expression patterns in 127 human tissues and cell types (Roadmap Epigenomics et al., 2015) . This integrative analysis was based on the global profile of histone modifications, DNA methylation, DNA accessibility, and RNA expression, along with genome-wide association studies, linking disease and trait-associated genetic variants to tissue-specific epigenomic marks. By applying this strategy to a mouse model of Alzheimer disease, a team from Manolis Kellis and Li-Huei Tsai's groups demonstrated that genetic variants associated with the disease are enriched in evolutionary conserved regulatory enhancers that control immune response genes linked to inflammation, but not neuronal pathways (Gjoneska et al., 2015) . These intriguing results suggest that the immune functions might be the major contributor to genetic predisposition to Alzheimer disease, whereas the cognitive decline could be linked to nongenetic environmental factors and identified new factors that could become novel therapeutic targets.
Joseph R. Ecker delivered a retrospective that illustrated the great advances in the exploration of mammalian methylomes based on novel whole genome bisulfite sequencing assays developed in his laboratory at The Salk Institute for Biological Studies, USA (Urich et al., 2015) . The genome-wide, base-resolution, DNA methylomes profiling has been pivotal in studying the widespread reconfiguration of methylation events occurring during development of frontal cortex (Lister et al., 2013) . Joseph Ecker addressed a major challenge by analyzing relatively homogenous populations of distinct neuronal subtypes through an innovative purification approach that allowed the identification of specific DNA methylation dynamics, which is key to unravel the epigenetic mechanisms essential for maturation and maintenance of distinct neuronal identities.
It was clear that profiling cell type-specific and disease state-specific epigenomic landscapes has a critical importance in understanding of how epigenetic changes can contribute to or drive neuronal identity and human disease.
Workshop: high-throughput sequencing for neuroepigenetics
Remarkable presentations were given during the highly informative workshop focused on the application of high-throughput sequencing methods to address fundamental questions in neuroscience. Particular emphasis was dedicated to the development of novel computational frameworks to elucidate complex epigenomic regulatory circuitries and to the epigenomic profiling of iPSCs as a strategy for modeling brain diseases.
As part of the Roadmap Epigenomics Program, Michael J. Ziller (Broad Institute of MIT and Harvard, USA) presented his extensive work on uncovering the epigenomic plasticity during neuronal differentiation (Ziller et al., 2015) . By integrating DNA methylation assays, chromatin immunoprecipitation, and gene expression analysis, Michael Ziller identified the epigenetic footprint distinguishing each cell state transition based on the progressive remodeling of the epigenetic landscape. Each differentiation stage was linked to the combinatorial actions of specific transcription factors, which was revealed by the novel computational framework (transcription factor epigenetic remodeling activity) based on the assessment of DNA binding motifs associated with distinct epigenetic states. This approach was decisive to shed light on regulatory mechanisms of cell fate decisions of neuronal development but also represents a general computational strategy for the systematic discovery of the epigenomic changes in a variety of biological systems.
The topic of modeling neurodevelopmental disorders by integrating epigenomic tools with iPSCs was presented by Matthew A. Lalli, a graduate student from the University of California Santa Barbara, USA. In his work, Matthew Lalli integrated global gene expression profiling of Williams syndrome-induced pluripotent neurons with genomic distribution by ChIP-seq of one of the genes deleted in Williams syndrome. His findings elucidate the epigenomic changes that are likely to contribute to the cognitive and behavioral phenotypes of the disorder, providing compelling evidence that the epigenomic profiling of iPSCs represents a powerful tool for modeling brain diseases and holds great promise for revealing cellular and behavioral phenotypes associated to patient-specific mutations.
Highlights from poster presentations
Exciting poster presentations covered all the aspect of neuroepigenetics. Michael Corley, who was awarded with the NIGMS Ancillary Training Program Scholarship for this conference, presented a remarkable study carried out in the laboratory of Alika Maunakea (Epigenomics Research Program of University of Hawai'i, USA), who was also a recipient of the Early-Career Investigator Travel Award. Their work focused on the comparative DNA methylomic analyses of the neurogenic subventricular zone from autism spectrum disorder-diagnosed postmortem brains, revealing substantial autism spectrum disorder-specific alterations of DNA methylation, with a stronger correlation with embryonic and neural stem cellspecific methylation states, providing novel evidence in support of the hypothesis that molecular alterations associated with autism arise early in development.
On a similar topic, Eran Mukamel (University of California, San Diego, USA) presented his work focused on novel genetic strategies to isolate distinct cortical neuron cell types, such as parvalbuminexpressing fast-spiking interneurons and vasoactive intestinal peptide-expressing interneurons. Transcriptome and wholegenome methylome profiling revealed cell type-specific patterns of non-CG methylation that covary with gene transcription across cortical neuron types. His approach provides a valid tool to study the epigenetic regulatory networks necessary to develop and maintain distinct neuronal identities.
Closing remarks and future perspectives
Apart from advancing our understanding of epigenetic mechanisms of neuronal function and dysfunction, the symposium cut across boundaries of molecular biology and classical behavioral neuroscience and provided a spirited discussion forum for promotion of crossdisciplinary collaborations between investigators that normally may not readily interact. Attendees of the symposium enthusiastically agreed that this meeting provided an important context for the communication and exchange of ideas that will have a major role in influencing the direction of research in this field. Moving forward, the integration of innovative sequencing technologies, big data analyses, disease modeling with iPSCs, and classical genetic and behavioral studies will provide a fertile ground for discoveries that will impact the basic understanding of neuronal function and catalyze new diagnostic and therapeutic strategies in disease.
